Marketable Securities, Current in USD of Nurix Therapeutics, Inc. from Q4 2021 to Q3 2023

Taxonomy & unit: us-gaap: USD
Description: Amount of investment in marketable security, classified as current.
Summary: Nurix Therapeutics, Inc. quarterly Marketable Securities, Current history and change rate from Q4 2021 to Q3 2023.
Nurix Therapeutics, Inc. Marketable Securities, Current for the quarter ending 31 Aug 2023 was $217M, a 27.1% decline year-over-year.

Marketable Securities, Current, Quarterly (USD)

Marketable Securities, Current, YoY Quarterly Change (%)

Nurix Therapeutics, Inc. Quarterly Marketable Securities, Current (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2023	$217M	-$80.4M	-27.1%	31 Aug 2023	10-Q	12 Oct 2023
Q2 2023	$222M			31 May 2023	10-Q	13 Jul 2023
Q1 2023	$244M			28 Feb 2023	10-Q	13 Apr 2023
Q4 2022	$245M	+$29.5M	+13.7%	30 Nov 2022	10-Q	12 Oct 2023
Q3 2022	$297M			31 Aug 2022	10-Q	06 Oct 2022
Q4 2021	$215M			30 Nov 2021	10-Q	06 Oct 2022

* An asterisk sign (*) next to the value indicates that the value is likely invalid.